Trade Summary

1 week ago, Sarchi Christopher, serving as Chief Commercial Officer at Replimune Group, Inc. (REPL), sold 6,500 shares at $8.01 per share, for a total transaction value of $52,065.00. Following this transaction, Sarchi Christopher now holds 151,588 shares of REPL.

This sale represents a 4.00% decrease in Sarchi Christopher's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 4 days after the trade was made.

Replimune Group, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.